EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $350,760 | +10.6% | 12,000 | 0.0% | 0.00% | – |
| Q3 2022 | $317,040 | -91.1% | 12,000 | -85.9% | 0.00% | -100.0% |
| Q1 2021 | $3,554,000 | -55.7% | 85,141 | -50.5% | 0.00% | -50.0% |
| Q4 2020 | $8,018,000 | +2.9% | 172,174 | -6.1% | 0.00% | 0.0% |
| Q3 2020 | $7,792,000 | -25.8% | 183,420 | -16.2% | 0.00% | -33.3% |
| Q2 2020 | $10,505,000 | +2.1% | 218,937 | -2.1% | 0.00% | -25.0% |
| Q1 2020 | $10,292,000 | -31.0% | 223,737 | -9.8% | 0.00% | 0.0% |
| Q4 2019 | $14,911,000 | +6.2% | 248,179 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $14,039,000 | +1.6% | 248,179 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $13,819,000 | +10.3% | 248,179 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,531,000 | +14.5% | 248,179 | -8.7% | 0.00% | 0.0% |
| Q4 2018 | $10,948,000 | -9.9% | 271,747 | +55.1% | 0.00% | 0.0% |
| Q3 2018 | $12,146,000 | +7.2% | 175,201 | +17.0% | 0.00% | 0.0% |
| Q2 2018 | $11,335,000 | +136.1% | 149,808 | +64.4% | 0.00% | +100.0% |
| Q1 2018 | $4,801,000 | -1.4% | 91,117 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,867,000 | +12.2% | 91,117 | +25.3% | 0.00% | 0.0% |
| Q3 2017 | $4,337,000 | -59.9% | 72,713 | -47.0% | 0.00% | -50.0% |
| Q2 2017 | $10,814,000 | +12.8% | 137,077 | +18.6% | 0.00% | 0.0% |
| Q1 2017 | $9,589,000 | +70.2% | 115,614 | +62.8% | 0.00% | +100.0% |
| Q4 2016 | $5,634,000 | +18.7% | 71,008 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,747,000 | – | 71,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |